Literature DB >> 1562702

Optimization of cervical cancer screening.

L Gustafsson1, H O Adami.   

Abstract

The aim of this study was to investigate how a screening program interacts with the dynamic natural history of cervical neoplasia in order to learn how screening for cervical cancer should be carried out most cost-effectively. For the purpose of optimization, the fundamental quantities of the natural history are the shape of the curve of age-specific prevalence rates of cancer in situ, and the duration of this stage before progression to invasive cancer. Since these quantities seem similar in different populations, the results probably can be generalized. Simulation studies revealed that optimal screening implies a nonperiodic schedule, and that this schedule is dependent not only on the number of screenings, but also on the efficiency of the screening rounds. With lower efficiency, the schedule should be concentrated into a shorter period. The effect of screening is also especially sensitive to the choice of age at the first and--to a smaller extent--last screening. The results concerning three different objectives also were compared, namely reduction of the cumulative number of invasive cancers, reduction of deaths due to cervical cancer, and reduction of years-of-life lost. The choice of objective also plays a role in the design of an optimal screening program. The theoretical approach in this analysis easily can be developed and accommodated to more complex individual situations such as prior screening histories and differing screening schedules in high- and low-risk women.

Entities:  

Mesh:

Year:  1992        PMID: 1562702     DOI: 10.1007/bf00051652

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  25 in total

1.  Prevalence of dysplasia and cancer of the cervix in a nationwide, planned parenthood population.

Authors:  S B Sadeghi; A Sadeghi; S J Robboy
Journal:  Cancer       Date:  1988-06-01       Impact factor: 6.860

2.  Estimates of the worldwide frequency of sixteen major cancers in 1980.

Authors:  D M Parkin; E Läärä; C S Muir
Journal:  Int J Cancer       Date:  1988-02-15       Impact factor: 7.396

3.  The role of cervical cytology in the declining morbidity and mortality of cervical cancer.

Authors:  D W Cramer
Journal:  Cancer       Date:  1974-12       Impact factor: 6.860

4.  Prevalence and incidence rates of cervical atypia. A computerized file analysis of 148,735 patients.

Authors:  M Bibbo; C M Keebler; G L Wied
Journal:  J Reprod Med       Date:  1971-04       Impact factor: 0.142

5.  Cervical cancer detection in British Columbia. A progress report.

Authors:  H K Fidler; D A Boyes; A J Worth
Journal:  J Obstet Gynaecol Br Commonw       Date:  1968-04

6.  A cohort study of cervical cancer screening in British Columbia.

Authors:  D A Boyes; B Morrison; E G Knox; G J Draper; A B Miller
Journal:  Clin Invest Med       Date:  1982       Impact factor: 0.825

7.  Cervical cytology screening in two Yorkshire areas: pattern of service.

Authors:  D M Parkin; W Collins; A D Clayden
Journal:  Public Health       Date:  1981-11       Impact factor: 2.427

8.  A computer simulation model for the practical planning of cervical cancer screening programmes.

Authors:  D M Parkin
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640

9.  Ages and frequencies for cervical cancer screening.

Authors:  E G Knox
Journal:  Br J Cancer       Date:  1976-10       Impact factor: 7.640

10.  Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation.

Authors:  L Gustafsson; H O Adami
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

View more
  7 in total

1.  Simulation optimization of PSA-threshold based prostate cancer screening policies.

Authors:  Daniel J Underwood; Jingyu Zhang; Brian T Denton; Nilay D Shah; Brant A Inman
Journal:  Health Care Manag Sci       Date:  2012-12

Review 2.  Calibration methods used in cancer simulation models and suggested reporting guidelines.

Authors:  Natasha K Stout; Amy B Knudsen; Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 3.  Cost-effective policies for cervical cancer screening. An international review.

Authors:  M C Fahs; S B Plichta; J S Mandelblatt
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

4.  Using simulation-optimization to construct screening strategies for cervical cancer.

Authors:  Laura A McLay; Christodoulos Foufoulides; Jason R W Merrick
Journal:  Health Care Manag Sci       Date:  2010-06-05

5.  Detection of genital human papillomavirus by single-tube nested PCR and type-specific oligonucleotide hybridization.

Authors:  N Ylitalo; T Bergström; U Gyllensten
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

6.  Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing.

Authors:  F Carozzi; G Ronco; M Confortini; D Noferini; C Maddau; S Ciatto; N Segnan
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

7.  Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix.

Authors:  L Gustafsson; P Sparén; M Gustafsson; E Wilander; R Bergström; H O Adami
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.